Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Latest News

Who Owns Medical Knowledge Now?

Doctors are no longer the only source of medical knowledge in the room, and the future may depend on who preserves the most humanity.

Why Some Teens Are Vulnerable to Substance Use Disorders

Emerging research suggests vulnerability to substance use disorders may begin before the first drink or drug. Drs Leslie A. Hulvershorn and Paola P. Mattey Mora explain why.

FDA Psychiatry Roundup: July 2026

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions.

The ‘Fourth Pillar of Cancer Care’ That’s Often Missed

Oncology has shown quitting tobacco improves outcomes. Now the field must learn how to incorporate cessation treatment alongside other cancer treatments.

Biosimilar Rituximab Matches Originator in ANCA Vasculitis

At 6 months, rituximab biosimilars show remission rates comparable to the originator in patients with granulomatosis with polyangiitis and microscopic polyangiitis, with no concerning safety signals.

Brain Health Lessons From Blue Zones

Kathrin LaFaver interviews fellow neurologist Aleksandra Pikula, who completed the Blue Zones certification from the American College of Lifestyle medicine on strategies for healthy brain aging.

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Latest News

Doctors are no longer the only source of medical knowledge in the room, and the future may depend on who preserves the most humanity.

Emerging research suggests vulnerability to substance use disorders may begin before the first drink or drug. Drs Leslie A. Hulvershorn and Paola P. Mattey Mora explain why.

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions.

Oncology has shown quitting tobacco improves outcomes. Now the field must learn how to incorporate cessation treatment alongside other cancer treatments.

At 6 months, rituximab biosimilars show remission rates comparable to the originator in patients with granulomatosis with polyangiitis and microscopic polyangiitis, with no concerning safety signals.

Kathrin LaFaver interviews fellow neurologist Aleksandra Pikula, who completed the Blue Zones certification from the American College of Lifestyle medicine on strategies for healthy brain aging.

News All Time

AI Detects AMD in Primary Care With High Accuracy

A new AI tool may screen for age-related macular degeneration using simple eye photos, with no need for dilation.

Medscape Poll: Antiamyloid Therapy in Alzheimer's Disease

Antiamyloid medications like lecanemab and donanemab can modestly slow cognitive decline in Alzheimer's disease, but clinicians remain divided on whether the benefits are meaningful enough and which patients may benefit most.

Workplace Heat Risk in Italy: A Growing Blind Spot

Italian workers remain poorly informed about heat risks, with many unable to recognize heatstroke or act quickly — a gap the WORKLIMATE project aims to close.

PARP Inhibitors for Prostate Cancer: 5 Things to Know

PARP inhibitors are reshaping the treatment landscape for metastatic prostate cancer, but who actually benefits, and how do we navigate the toxicity and testing gaps to use them wisely?

Cerebral Venous Sinus Thrombosis Following Meningitis in Man

A man develops delayed cerebral venous sinus thrombosis after pneumococcal meningitis despite apparent treatment success, highlighting persistent headache as a warning sign.

What’s Driving the Hormone Therapy Surge?

After more than two decades of conservative prescribing, data from Epic show a sharp increase in hormone therapy orders for women who may be experiencing perimenopause or menopause.

Kids With Complexity May Miss Posthospital PCP Visits

Children with vs without medical complexity are less likely to complete primary care follow-up after hospitalization, and those who attend follow-up have a higher risk of being readmitted.

Autism Rates Surge Post-Pandemic in Female Patients

US autism diagnoses surged after 2020 in female patients but remained stable or declined in male patients, a new study shows.

How Gut Microbes Link to Sleep After Hydrogen Supplement

Individuals with lower abundance of hydrogen-producing gut bacteria may show improvement in sleep quality after hydrogen supplementation, per an exploratory analysis.

Is It Ethical for Doctors to Hawk Products in the Office?

Doctors selling supplements and products in the office is becoming more common, but is it ethical?

Does Brazil Hold the Keys to Extreme Human Longevity?

Brazil’s genetically diverse population may offer a unique opportunity to advance research into the biological and environmental drivers of exceptional longevity.

Is ‘Brain Rot’ Real? What Short Videos May Do to Cognition

Emerging evidence suggests that while short-form videos may engage learners, they may also disrupt attention, memory, and brain networks essential for effective learning.

Going Dye-Free for IBD Surveillance: How Well Does It Work?

Virtual chromoendoscopy based on linked color imaging shows comparable performance to traditional dye-based chromoendoscopy for detecting neoplasia in patients with IBD.

Fecal Transplant Tied to Improved Sleep in Chronic Insomnia

A fecal microbiota transplantation protocol is linked to improved sleep efficiency and reduced wake after sleep onset in adults with chronic insomnia disorder, new research shows.

Self-Management Toolkit Cuts Hospital Costs for Parkinson's

A facilitated self-management intervention for Parkinson's disease improves daily functioning and reduces healthcare costs over 12 months, driven primarily by fewer unplanned hospital admissions.

Which Cancers Are Still More Deadly in Black Patients?

A comprehensive analysis of the cancer mortality gap between Black and White people shows progress overall, but disparities in a few types are unchanged or worse.